Amanote Research
Register
Sign In
Treatment Pathways and Resource Use Associated With Recurrent Hodgkin Lymphoma After Autologous Stem Cell Transplantation
Bone Marrow Transplantation
- United Kingdom
doi 10.1038/bmt.2016.244
Full Text
Open PDF
Abstract
Available in
full text
Categories
Transplantation
Hematology
Date
January 16, 2017
Authors
J Radford
P McKay
R Malladi
R Johnson
A Bloor
F Percival
A Sureda
K S Peggs
Publisher
Springer Science and Business Media LLC
Related search
Autologous Stem Cell Transplantation Outcomes in Elderly Patients With B Cell Non-Hodgkin Lymphoma
British Journal of Haematology
Hematology
Autologous Peripheral Blood Stem Cell Transplantation in Children and Adolescents With Non‑Hodgkin Lymphoma
Oncology Letters
Cancer Research
Oncology
Cost-Effectiveness Analysis of Consolidation With Brentuximab Vedotin for High-Risk Hodgkin Lymphoma After Autologous Stem Cell Transplantation
Cancer
Cancer Research
Oncology
Monoclonal Antibodies and Autologous Stem Cell Transplantation for Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
Autologous Peripheral Blood Stem Cell Transplantation for Adult Patients With B-Cell Lymphoma-Associated Hemophagocytic Syndrome
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Outcomes of Autologous Stem Cell Transplantation (ASCT) in Patients With Relapsed/Refractory HIV-associated Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
Ulcerative Colitis After Autologous Peripheral Blood Stem Cell Transplantation for Non-Hodgkin’s Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
Infections Following Autologous Stem Cell Transplantation for Hodgkin'S Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Prognostic Variables of Progression Free Survival in Mantle Cell Lymphoma After Autologous Stem Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
